Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples
Authors:
Open Access
- 11 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11, 541092
Abstract
Background: Metagenomic next-generation sequencing (mNGS) is a powerful method for pathogen detection. In this study, we assessed the value of mNGS for bronchoalveolar lavage (BAL) samples in the diagnosis of pulmonary infections. Methods: From February 2018 to April 2019, BAL samples were collected from 235 patients with suspected pulmonary infections. mNGS and microbial culture were performed to evaluate the effectiveness of mNGS in pulmonary infection diagnosis. Results: We employed mNGS to evaluate the alpha diversity, results suggesting that patients with confirmed pathogens had a lower microbial diversity index compared to that of patients with uncertain pathogens. For the patients admitted to the respiratory intensive care unit (RICU) or on a ventilator, they experienced a lower diversity index than that of the patients in the general ward or not on a ventilator. In addition, mNGS of BAL had a diagnostic sensitivity of 88.89% and a specificity of 14.86% in pulmonary infection, with 21.16% positive predictive value (PPV) and 83.87% negative predictive value (NPV). When rare pathogens were excluded, the sensitivity of mNGS decreased to 73.33%, and the specificity increased to 41.71%. For patients in the simple pulmonary infection group and the immunocompromised group, the main infection types were bacterial infection (58.33%) and mixed-infection (43.18%). Furthermore, mNGS had an advantage over culture in describing polymicrobial ecosystem, demonstrating the microbial distribution and the dominant strains of the respiratory tract in patients with different underlying diseases. Conclusions: The study indicated that mNGS of BAL samples could provide more accurate diagnostic information in pulmonary infections and demonstrate the changes of respiratory microbiome in different underlying diseases. This method might play an important role in the clinical use of antimicrobial agents in the future.Keywords
This publication has 44 references indexed in Scilit:
- Decade-long bacterial community dynamics in cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory TractAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Viral Infection in Acute Exacerbation of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPDPLOS ONE, 2011
- Torque Teno Virus Viremia Load Size in Patients with Selected Congenital Defects of Innate ImmunityClinical and Vaccine Immunology, 2011
- Antibiotic Use in Thailand: Quantifying Impact on Blood Culture Yield and Estimates of Pneumococcal Bacteremia IncidenceThe American Journal of Tropical Medicine and Hygiene, 2010
- Disordered Microbial Communities in Asthmatic AirwaysPLOS ONE, 2010
- Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis IndividualsPLOS ONE, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009